Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · IEX Real-Time Price · USD
8.87
-0.08 (-0.89%)
At close: May 17, 2024, 4:00 PM
8.89
+0.02 (0.23%)
After-hours: May 17, 2024, 4:00 PM EDT
Centessa Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CNTA stock have an average target of 10, with a low estimate of 5.00 and a high estimate of 15. The average target predicts an increase of 12.74% from the current stock price of 8.87.
Analyst Consensus: Buy
* Price targets were last updated on Apr 1, 2024.
Analyst Ratings
The average analyst rating for CNTA stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BMO Capital | BMO Capital | Buy Maintains $15 | Buy | Maintains | $15 | +69.11% | Apr 1, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $4 → $11 | Hold → Strong Buy | Upgrades | $4 → $11 | +24.01% | Nov 15, 2023 |
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $4 → $8 | Sell → Hold | Upgrades | $4 → $8 | -9.81% | Oct 26, 2023 |
SVB Securities | SVB Securities | Buy Maintains $6 → $11 | Buy | Maintains | $6 → $11 | +24.01% | Aug 15, 2023 |
Guggenheim | Guggenheim | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +12.74% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 6.85M
Revenue Next Year
n/a
EPS This Year
-1.85
from -1.57
EPS Next Year
-1.90
from -1.85
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 57.3M | 191.1M | 287.7M |
Avg | n/a | n/a | 42.9M | 123.8M | 199.3M |
Low | n/a | n/a | 18.3M | 80.2M | 124.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 345.3% | 132.4% |
Avg | - | - | - | 188.5% | 61.0% |
Low | - | - | - | 86.8% | 0.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.72 | -1.93 | -0.93 |
Avg | -1.85 | -1.90 | -1.38 |
Low | -1.97 | -1.84 | -1.66 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.